Takeda Pharmaceutical
TAK
#485
Rank
HK$330.19 B
Marketcap
HK$104.15
Share price
0.38%
Change (1 day)
-4.58%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2024 (TTM): HK$9.41 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$29.30 Billion. In 2023 the company made an earning of HK$17.77 Billion a decrease over its 2022 earnings that were of HK$24.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$9.41 B-47.01%
2023 HK$17.77 B-28.11%
2022 HK$24.72 B-41.15%
2021 HK$42.01 B78.15%
2020 HK$23.58 B246.83%
2019 HK$6.79 B-48.74%
2018 HK$13.26 B-23.86%
2017 HK$17.42 B21.77%
2016 HK$14.30 B-253.22%
2015 -HK$9.34 Billion-159.7%
2014 HK$15.64 B12.76%
2013 HK$13.87 B2.7%
2012 HK$13.50 B-57.11%
2011 HK$31.49 B-10.11%
2010 HK$35.03 B-4.2%
2009 HK$36.56 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$143.18 B 1,422.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$57.66 B 513.14%๐Ÿ‡ซ๐Ÿ‡ท France
-HK$9.44 Billion-200.32%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$99.10 B 953.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$6.16 Billion-165.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.79 B-27.79%๐Ÿ‡ฎ๐Ÿ‡ณ India
HK$36.42 B 287.28%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$32.46 B 245.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$128.35 B 1,264.86%๐Ÿ‡บ๐Ÿ‡ธ USA